To describe the prenatal presentation, including ultrasonographic, histologic, and molecular findings, in 2 fetuses affected with LMOD3-related nemaline myopathy. Prenatal ultrasonographic examinations and histopathologic studies were performed on 2 fetuses with evidence of nemaline myopathy. To establish a molecular diagnosis, whole-exome sequencing was pursued for the affected fetuses. Nemaline myopathy is a common form of congenital myopathy manifesting with nonprogressive generalized muscle weakness, hypotonia, and electron-dense protein inclusions in skeletal myofibers. Although clinically, nemaline myopathy can be viewed as a common pathway phenotype, its molecular basis is heterogeneous, with mutations in 11 identified genes implicated in its pathogenesis so far. Whole-exome sequencing revealed that the affected fetuses were compound heterozygous for 2 newly reported pathogenic variants in the LMOD3 gene, which encodes leiomodin 3. To our knowledge, this article is the first report of LMOD3-related nemaline myopathy since the original reported cohort. We provide a detailed description of the prenatal imaging of these affected fetuses, which we hope, in combination with nextgeneration sequencing, may contribute to further diagnosis in additional families.
N emaline myopathy is a congenital myopathy manifesting with nonprogressive generalized muscle weakness and hypotonia, as well as electron-dense protein inclusions in skeletal myofibers. Although clinically, nemaline myopathy can be seen as a final common pathway phenotype, its molecular basis is heterogeneous, with mutations in 11 genes implicated in its pathogenesis so far. 1 One of the recently described associations was to variants in the LMOD3 gene, which encodes leiomodin 3, a member of the tropomodulin family of proteins, which is expressed in skeletal muscle from the early stages of differentiation and plays a role in actin thinfilament nucleation. 2 In their first description of this autosomal recessive nemaline myopathy (Online Mendelian Inheritance in Man No. 616165), Yuen et al 3 used next-generation sequencing techniques to identify 21 individuals from 14 families with severe and early-onset nemaline myopathy and causative homozygous or compound heterozygous mutations in LMOD3. Furthermore, they demonstrated thinfilament shortening and disorganization in muscle biopsies of LMOD3-deficient patients and showed that a zebrafish model of lmod3 knockdown recapitulated the human phenotype. 3 Later, 2 mouse models of LMOD3 knockdown further confirmed the crucial role of leiomodin 3 in sarcomere assembly and the causative association between its deficiency and the nemaline myopathy phenotype. 4, 5 Interestingly, LMOD3 was also shown to play a role in the pathologic mechanism of other types of nemaline myopathy. For instance, another severe autosomal recessive form of nemaline myopathy is caused by variants in the KLHL40 (Kelch-like 40) gene, which has been shown to bind LMOD3 and promote its stability. 6, 7 Furthermore, LMOD3 levels were shown to be significantly reduced in both patients and a mouse model of KLHL40-associated nemaline myopathy. 7 To our knowledge, this article is the first report of LMOD3-related nemaline myopathy since the original reported cohort 3 and the first report of a prenatal diagnosis of this disorder. Here we report a detailed description of the prenatal imaging and pathologic findings of the 2 affected fetuses and strengthen the growing impact of the use of next-generation sequencing in deciphering the cause of abnormal prenatal findings such as arthrogryposis. The family reported herein offers the opportunity to further delineate the prenatal presentation of LMOD3-related nemaline myopathy.
Interestingly, the reported family first presented for clinical attention after a previous unrelated diagnosis of G syndrome in several affected individuals in the extended family, who had a MID1 (midline 1) mutation, for which the mother was heterozygous. The co-occurrence of G syndrome and LMOD3-related nemaline myopathy found in this family is an example of dual diagnosis, a phenomenon that is recently gaining widespread attention with the growing use of next-generation sequencing.
Materials and Methods
Following Institutional Review Board approval, written informed consent was obtained from the couple.
Clinical Report
A healthy nonconsanguineous couple was referred for genetic counseling. The mother was a 40-year-old woman of Jewish Egyptian-Iraqi origin, and the father was a 40-year-old man of Jewish Moroccan origin. The extended family history was notable for a maternal brother who was born with cleft lip and palate, hypertelorism, hypospadias, and a developmental delay; another maternal brother had syringomelia and Arnold-Chiari malformation type I; and a maternal uncle presented with cleft lip and palate and hypertelorism. In addition, a maternal aunt had a history of 4 affected boys; 1 of these boys was born with cleft lip and palate and spina bifida; another was born with cleft lip and palate and died of a severe respiratory disorder; the fourth was born with cleft lip and palate and died of respiratory complications; in addition, she had 8 miscarriages (Figure 1 ). The paternal family tree was noncontributory, with no known cases of congenital malformations or other genetic disorders. Based on this family history, a clinical diagnosis of G syndrome (also termed Opitz GBBB syndrome type I; Online Mendelian Inheritance in Man No. 300000) was confirmed by the identification of a 950insA nonsense mutation in the MID1 gene, for which the mother was found to be a heterozygous carrier. This confirmation enabled her to pursue prenatal diagnosis by means of DNA testing from chorionic villus sampling, and indeed one pregnancy was terminated after a prenatal diagnosis of G syndrome in the fetus. The couple had 3 healthy children (2 girls and 1 boy).
Although the initial indication for genetic counseling of the couple was the diagnosis of G syndrome in the maternal family, they then returned for repeated counseling during their third pregnancy (female fetus), this time for abnormal ultrasonographic (US) findings at 26 weeks' gestation, which showed no fetal movements, mild polyhydramnios, a small stomach, a suspected right clubfoot, and extended lower limbs ( Figure 2 ). The hands were clenched, and the head was in a stiff, hyperextended position. Fetal brain magnetic resonance imaging findings were normal, and molecular analysis for a spinal muscular atrophy deletion was normal. A postmortem evaluation was pursued (see below).
The fourth pregnancy (female fetus) was terminated at a gestational age of 30 weeks 4 days because of US findings that were similar to those seen in the previous affected fetus. The putative diagnosis of autosomal recessive arthrogryposis was discussed with the family. Of note, before the abnormal US findings, both of these fetuses were evaluated (via chorionic villus sampling) and found not to harbor the maternal MID1 mutation.
Whole-Exome Sequencing
After written informed consent was obtained from the parents, genomic DNA was extracted from whole-blood samples from the 2 affected fetuses and from the couple. Whole-exome sequencing was performed using an Agilent v5 exome capture kit and the HiSeq 2500 sequencing platform (Illumina Inc, San Diego, CA). Reads were aligned with the human reference genome (hg19; National Center for Biotechnology Information [Bethesda, MD] build 37; February 2009) using a Burrows-Wheeler transform. 8 Variant calling was performed with the Genome Analysis Toolkit 9 and functionally annotated using KGGSeq. 10 
Results

Histopathologic Studies
The third pregnancy was terminated at 26 weeks' gestation. The female fetus, weighing 870 g, was appropriate for gestational age. The fetus presented with an apparently large head relative to a narrow chest, abdomen, and pelvis. The muscular mass of the extremities was depleted. The elbows and wrists were flexed but movable, whereas the hip, knees, and ankles were partially contracted. Histologic sections of skeletal muscle obtained from the extremities showed muscle fiber loss and replacement by fibrosis ( Figure 3B ). Due to fiber loss, the muscle bundles showed marked variability in size and were surrounded by thick irregular fibrous bands ( Figure 3B ). Bright red eosinophilic bodies, consistent with nemaline bodies, were found in numerous muscle fibers. An approximation to sarcolemma or a Z line was identified in the more preserved fibers ( Figure  3, C and D) , as described previously.
3 Histologic sections of the brain were within normal limits. Given together, these autopsy findings were compatible with the diagnosis of nemaline myopathy.
Whole-Exome Sequencing
Whole-exome sequencing performed for one of the fetuses, and her parents yielded 16,772 heterozygous variants; this list was reduced to 731 rare variants affecting protein-coding sequences and transcript processing by filtering out variants present in 0.01 or more of our in-house exomes (n 5 725) and variants present with a minor allele frequency of 0.01 or greater in either the A compound heterozygote analysis revealed 2 new mutations in the LMOD3 gene (NM_198271), which has been previously associated with nemaline myopathy.
A segregation analysis confirmed the biparental transmission of the paternal nonsense mutation (Glu121ArgfsTer5) and the maternal deletion mutation (L245del). Both fetuses were compound heterozygous, whereas the parents were heterozygous carriers for each of these variants, respectively. The unaffected male sibling was found to be a heterozygous carrier of one of these mutations, whereas the unaffected female siblings were wild type for both mutations. Both mutations were not found in the in-house whole-exome sequencing database, which includes approximately 725 exomes, in the records of the 1000 Genomes variants, or in the Exome Sequencing Project database.
Discussion
Here we report a nonconsanguineous couple who initially presented for genetic counseling because of G syndrome, which was confirmed by molecular diagnosis of the MID1 gene (950insA) in the family. The couple pursued prenatal molecular diagnosis for this disorder by chorionic villus sampling at 11 weeks' gestation for 2 successive pregnancies, with both fetuses found to be wild type for the familial MID1 mutation. Unfortunately, arthrogryposis was identified by prenatal US in both pregnancies. Arthrogryposis refers to a large heterogeneous group of conditions, characterized by contracted muscles and nonprogressive congenital limitation of movement of 2 or more different joints with thick periarticular capsules. 11 Arthrogryposis occurs in approximately 1 per 3000 to 1 per 5000 neonates, and male and female neonates are equally affected. It is observed in a number of heterogeneous disorders that cause decreased fetal joint movements leading to akinesia/hypokinesia, polyhydramnios, intrauterine growth restriction, multiple joint contractures, facial dysmorphism, increased nuchal translucency/cystic hygroma, abnormal presentations, developmental anomalies, and early mortality. Indeed, arthrogryposis has been reported in association with fetal neuropathic, neuromuscular, connective tissue, and metabolic disorders as well as acquired ("extrafetal") conditions such as intrauterine constraint, maternal diseases such as myasthenia gravis, and maternal/fetal exposure to cytomegalovirus and other teratogens.
Nemaline myopathy belongs to the group of congenital myopathies that represent one of the causes leading to arthrogryposis. It is also a heterogeneous disorder that affects approximately 1 per 50,000 individuals and is defined by the presence of nonprogressive generalized muscle weakness and numerous electron-dense protein inclusions (nemaline bodies or rods) in skeletal myofibers. 12 The diagnosis of nemaline myopathy is based on clinical findings, nemaline bodies on muscle biopsy, and detection of genetic pathogenic variants in 1 of the 11 genes currently known to cause this disorder. 13 The 2 affected fetuses described here presented with severely reduced fetal movements and contractures. The US findings were compatible with a severe degree of arthrogryposis/congenital myopathy. Both fetuses presented with prenatal findings described in prenatal cases of LMOD3-associated nemaline myopathy, including polyhydramnios (62% of patients), decreased or absent fetal movements (48% of patients), and joint contractures (often multiple, 48% of patients). 3 Nevertheless, these findings are not specific for LMOD3-associated nemaline myopathy, since they are reported in other forms of nemaline myopathy and severe congenital myopathies. Finally, the histopathologic studies, which showed the typical nemaline bodies and atrophic myofibers, were compatible with the diagnosis of nemaline myopathy (Figure 3 ). In addition, interstitial connective tissue was increased, a sign indicative of myopathy (nemaline myopathy or otherwise), albeit nonspecific, and consistent with the histopathologic findings described by Yuen et al. 3 Identification of the etiology of prenatal arthrogryposis is challenging because it has been recognized in more than 400 different conditions, with more than 320 genes implicated to date, 9,14-16 whereas nemaline myopathy has been associated with 11 distinct genes thus far. With next-generation sequencing, 2 newly reported frameshift mutations, which were segregated in the family according to autosomal recessive inheritance, were identified in both fetuses.
Massive parallel sequencing of whole genomes and exomes is nowadays an effective tool for direct assessment of causative genetic variations, enabling the identification of genetic factors involved in rare diseases with mendelian inheritance patterns. The diagnostic yield of trio-whole-exome sequencing pursued for fetuses with US abnormalities has been reported to range from 21% to 57%, based on small published cohorts, [17] [18] [19] [20] although the diagnostic rates differ according to phenotype and consanguineous versus nonconsanguineous families and are also subject to a welldescribed ascertainment bias.
Importantly, in this family, the early and severe prenatal US findings allowed us to focus the whole-exome sequencing interpretation on the arthrogryposis-and nemaline myopathy-associated genes. The fetuses were compound heterozygous for 2 novel frameshift mutations, each of them inherited from either parent. The E121FS*5 variant is located within the glutamic acid-rich domain, whose function is still not clear, whereas the L245del is located within the leucine-rich repeat domain, one of the 3 actin-binding domains (actin-binding helix, Wiskott-Aldrich-syndrome protein homology 2 domain). Both variants are predicated to truncate the LMOD3 protein. This idea is in line with most of the LMOD3 mutations reported until now, which are nonsense or frameshift mutations that would truncate the LMOD3 protein if expressed. 3 For years, clinicians have been trained under the paradigm of the "Occam razor," meaning that a single etiology would be expected to explain all signs and symptoms. However, in recent years, with the growing use of next-generation sequencing technologies, more and more patients are found to be affected by more than 1 genetic disorder (a phenomenon termed "dual diagnosis"). This factor has substantial implications in terms of the diagnostic algorithm, care of the affected child, accurate genetic counseling, and family planning. The family reported herein underscores the importance of keeping an open mind with regard to the possibility of a dual diagnosis.
In summary, we report on the co-occurrence of nemaline myopathy due to compound heterozygous newly reported mutations in the LMOD3 gene and G syndrome due to an MID1 mutation in a single family. Although the prenatal clinical features of LMOD3-related nemaline myopathy may be indistinguishable from those of other forms of nemaline myopathy, nextgeneration sequencing techniques offer an effective means toward a timely molecular diagnosis. Finally, we suggest that LMOD3 variants should be considered in cases of prenatal diagnosis of arthrogryposis and nemaline myopathy.
